Framework agreement for the supply of Denosumab 60 mg and 120 mg

Summary

The framework agreement concerns the supply of Denosumab 60 mg and 120 mg in Belgium under an arrangement with AZ Sint-Lucas vzw Brugge. The tender comprises two lots: Lot 1 Denosumab 60 mg with a framework maximum of EUR 30,000; Lot 2 Denosumab 120 mg with a framework maximum of EUR 195,000. The framework lasts two years and may be extended twice by one year; extensions are automatic unless the parties notify otherwise; a notice of extension must be given at least 90 calendar days before the end date of the contract.